Last reviewed · How we verify
OCTAPLAS
OCTAPLAS is a Small molecule drug developed by University College, London. It is currently FDA-approved. Also known as: plasma exchange, octaplas.
At a glance
| Generic name | OCTAPLAS |
|---|---|
| Also known as | plasma exchange, octaplas |
| Sponsor | University College, London |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket Trial (PHASE2)
- Randomized Control Study in REsuscitation of SEpsis Trial (PHASE4)
- Pooled Human Plasma vs Crystalloid in The Management of Children Undergoing Instrumented Spinal Fusion for Scoliosis (PHASE3)
- Study of Plasma Exchange in Severe COVID-19 (PHASE2)
- Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock (SHOCK) Trial (PHASE2)
- Octaplas Pediatric Plasma Replacement Trial (PHASE4)
- Octaplas Pediatric Plasma Exchange Trial (PHASE4)
- Octaplas Adult TTP Trial
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- OCTAPLAS CI brief — competitive landscape report
- OCTAPLAS updates RSS · CI watch RSS
- University College, London portfolio CI
Frequently asked questions about OCTAPLAS
What is OCTAPLAS?
OCTAPLAS is a Small molecule drug developed by University College, London.
Who makes OCTAPLAS?
OCTAPLAS is developed and marketed by University College, London (see full University College, London pipeline at /company/university-college-london).
Is OCTAPLAS also known as anything else?
OCTAPLAS is also known as plasma exchange, octaplas.
What development phase is OCTAPLAS in?
OCTAPLAS is FDA-approved (marketed).
Related
- Manufacturer: University College, London — full pipeline
- Also known as: plasma exchange, octaplas
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing